Mitochondria as disease-relevant organelles in rheumatoid arthritis
Open Access
- 24 November 2022
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 211 (3), 208-223
- https://doi.org/10.1093/cei/uxac107
Abstract
Mitochondria are the controllers of cell metabolism and are recognized as decision makers in cell death pathways, organizers of cytoplasmic signaling networks, managers of cellular stress responses and regulators of nuclear gene expression. Cells of the immune system are particularly dependent on mitochondrial resources, as they must swiftly respond to danger signals with activation, trafficking, migration, and generation of daughter cells. Analogously, faulty immune responses that lead to autoimmunity and tissue inflammation rely on mitochondria to supply energy, cell building blocks and metabolic intermediates. Emerging data endorse the concept that mitochondrial fitness, and the lack of it, is of particular relevance in the autoimmune disease rheumatoid arthritis (RA) where deviations of bioenergetic and biosynthetic flux affect T cells during early and late stages of disease. During early stages of RA, mitochondrial deficiency allows naïve RA T cells to lose self-tolerance, biasing fundamental choices of the immune system towards immune-mediated tissue damage and away from host protection. During late stages of RA, mitochondrial abnormalities shape the response patterns of RA effector T cells engaged in the inflammatory lesions, enabling chronicity of tissue damage and tissue remodeling. In the inflamed joint, autoreactive T cells partner with metabolically reprogrammed tissue macrophages that specialize in antigen-presentation and survive by adapting to the glucose-deplete tissue microenvironment. Here, we summarize recent data on dysfunctional mitochondria and mitochondria-derived signals relevant in the RA disease process that offer novel opportunities to deter autoimmune tissue inflammation by metabolic interference.Keywords
Funding Information
- National Institutes of Health (R01AR042527, R01AI108906, R01HL142068, P01HL129941, R01AI108891, R01AG045779, U19AI057266, R01AI129191)
This publication has 123 references indexed in Scilit:
- IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activationArthritis Research & Therapy, 2013
- PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cellsNature, 2012
- TAM receptor signaling and autoimmune diseaseCurrent Opinion in Immunology, 2010
- DNA‐dependent protein kinase catalytic subunit mediates T‐cell loss in rheumatoid arthritisEMBO Molecular Medicine, 2010
- Immune Aging and Rheumatoid ArthritisRheumatic Disease Clinics of North America, 2010
- The cell-type specificity of mitochondrial dynamicsThe International Journal of Biochemistry & Cell Biology, 2009
- Deficiency of the DNA repair enzyme ATM in rheumatoid arthritisThe Journal of Experimental Medicine, 2009
- Telomerase insufficiency in rheumatoid arthritisProceedings of the National Academy of Sciences of the United States of America, 2009
- Opening and closing the metabolite gateProceedings of the National Academy of Sciences of the United States of America, 2008
- BAFF controls B cell metabolic fitness through a PKCβ- and Akt-dependent mechanismThe Journal of Experimental Medicine, 2006